Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Positron Emission Tomography01:29

Positron Emission Tomography

6.2K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
6.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Alterations in Skin Microbiota in Patients with Spinocerebellar Ataxia Type 3: A Pilot Study.

Current neuropharmacology·2026
Same author

Haplotype-resolved methylomes reveal parent-of-origin DNA methylation imbalance in autism spectrum disorder.

Science advances·2026
Same author

Interpretable Machine Learning Model for Individualized Survival Prediction of Multiple System Atrophy.

Movement disorders : official journal of the Movement Disorder Society·2026
Same author

The fT3/fT4 ratio as a candidate marker of motor progression in SCA3.

Neurobiology of disease·2026
Same author

Lysine acetyltransferase 8-mediated histone acetylation, regulated by GBA1, is associated with lysosomal function related to α-Synuclein pathology.

Cell death & disease·2026
Same author

Genomic Landscape and Phenotypic Spectrum of Autosomal Recessive Cerebellar Ataxia in China.

Movement disorders : official journal of the Movement Disorder Society·2026

Related Experiment Video

Updated: May 6, 2026

The Neuromuscular Junction: Measuring Synapse Size, Fragmentation and Changes in Synaptic Protein Density Using Confocal Fluorescence Microscopy
12:18

The Neuromuscular Junction: Measuring Synapse Size, Fragmentation and Changes in Synaptic Protein Density Using Confocal Fluorescence Microscopy

Published on: December 26, 2014

21.7K

Synaptic Density Reductions in MSA: A Potential Biomarker Identified Through [18F]SynVesT-1 PET Imaging.

Jian Li1, Daji Chen2, Yongxiang Tang1

  • 1Department of Nuclear Medicine, Xiangya Hospital, Central South University, Changsha, People's Republic of China.

Annals of Neurology
|January 20, 2025
PubMed
Summary

Multiple system atrophy (MSA) shows widespread synaptic density loss, especially in the basal ganglia and infratentorial regions. [18F]SynVesT-1 PET imaging can help diagnose MSA and monitor disease severity.

More Related Videos

Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis
08:40

Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis

Published on: February 28, 2021

3.8K
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

1.1K

Related Experiment Videos

Last Updated: May 6, 2026

The Neuromuscular Junction: Measuring Synapse Size, Fragmentation and Changes in Synaptic Protein Density Using Confocal Fluorescence Microscopy
12:18

The Neuromuscular Junction: Measuring Synapse Size, Fragmentation and Changes in Synaptic Protein Density Using Confocal Fluorescence Microscopy

Published on: December 26, 2014

21.7K
Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis
08:40

Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis

Published on: February 28, 2021

3.8K
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

1.1K

Area of Science:

  • Neuroscience
  • Radiology
  • Biomarker Discovery

Background:

  • Multiple system atrophy (MSA) is a progressive neurodegenerative disorder.
  • Accurate diagnosis and monitoring of disease severity in MSA remain challenging.
  • Synaptic dysfunction is a key pathological feature in MSA.

Purpose of the Study:

  • To assess synaptic density alterations in patients with MSA using [18F]SynVesT-1 positron emission tomography/computed tomography (PET/CT).
  • To evaluate the potential of [18F]SynVesT-1 PET/CT as a biomarker for MSA diagnosis and disease severity.
  • To differentiate between MSA subtypes (MSA-P and MSA-C) and Parkinson's disease (PD) based on synaptic density patterns.

Main Methods:

  • Prospective study involving 60 MSA patients (30 MSA-P, 30 MSA-C), 30 PD patients, and 30 healthy controls (HCs).
  • All participants underwent [18F]SynVesT-1 PET/CT imaging for synaptic density assessment.
  • Visual, voxel, and region of interest (VOI) analyses were performed, with diagnostic performance evaluated by receiver operating characteristic (ROC) analysis. Spearman correlation assessed the relationship between synaptic density and disease severity.

Main Results:

  • Patients with MSA exhibited significant reductions in synaptic density across multiple brain regions, including the cerebellum, putamen, medulla oblongata, ventral tegmental area, and pons.
  • MSA-C patients showed marked cerebellar synaptic loss, while MSA-P patients had significant synaptic loss in the posterior putamen.
  • MSA patients displayed more pronounced infratentorial synaptic density reduction compared to PD patients. VOI-based analysis significantly outperformed visual assessment for MSA diagnosis and subtype differentiation.
  • Brain synaptic density correlated significantly with motor function scales in MSA patients.

Conclusions:

  • Widespread synaptic density reductions are characteristic of MSA, particularly in the basal ganglia and infratentorial areas.
  • [18F]SynVesT-1 PET/CT shows promise as a biomarker for diagnosing MSA and assessing disease progression.
  • This imaging technique could guide future synaptic restoration therapies in MSA.